Evaluating the Cardioprotective Effects of Melatonin in Non-metastatic Breast Cancer Patients Receiving Doxorubicin Plus Cyclophosphamide: A Triple-Blind, Placebo-Controlled Randomized Controlled Trial
Melatonin may be effective in the prevention of doxorubicin-induced cardiotoxicity based on the improvement in GLS and biomarker levels.
Authors
- Mohsen Esfandbod (ORCID: https://orcid.org/0000-0002-6497-2306)
- Kamran Roudini (ORCID: https://orcid.org/0000-0003-0166-0505)
- Farnoosh Larti (ORCID: https://orcid.org/0000-0001-7939-9306)
- Marzieh Lashkari (ORCID: https://orcid.org/0000-0001-9286-0371)
- Zahra Jahangard‐Rafsanjani (ORCID: https://orcid.org/0000-0001-9791-1991)
- Amir Hossein Emami
- Hossein Ranjbar
- Seyyed Mohammad Mousavinia (ORCID: https://orcid.org/0009-0009-3098-7663)
Institutions
- Imam Khomeini Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Iranian journal of pharmaceutical research
- Published
- 2025-10-20
- DOI
- https://doi.org/10.5812/ijpr-162962
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tehran University of Medical Sciences and Health Services